Medical Research Council forms new deals with industry

The Medical Research Council (MRC) has announced that, building on its track record in establishing innovative collaborations with industry, it has formed partnerships with the global pharmaceutical companies UCB and AstraZeneca. It is envisaged that these deals will help speed up the translation of discovery research into potential therapies by giving academic researchers the chance to use industry infrastructure and expertise. These partnerships will allow researchers to apply for access to AstraZeneca’s high-throughput screening tools and also to access UCB’s cutting edge antibody discovery process.

The news article can be found here.

Tagged with

Published on 2. August 2017 in News UK